Literature DB >> 12047253

Review article: medical treatment of severe ulcerative colitis.

M Daperno1, R Sostegni, R Rocca, C Rigazio, N Scaglione, F Castellino, E Ercole, A Pera.   

Abstract

Approximately 15% of patients with ulcerative colitis have a severe attack requiring hospitalization at some time during their illness. This treatment leads to a remission in 60-80% of patients and non-responders may require a total colectomy. Mortality in severe episodes of ulcerative colitis decreased from 31-61% in the 1950s to 5-9% in the 1960s thanks to the introduction of steroids and to a policy of early colectomy. Recently, some new drugs have been shown to be effective in the treatment of severe steroid-refractory ulcerative colitis. This review concentrates on the clinical evaluation, prognostic factors and new developments in medical therapy in severe ulcerative colitis. A retrospective evaluation of a consecutive series of patients with severe ulcerative colitis admitted to a Gastroenterology Department in Torino, Italy, is also reported.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047253     DOI: 10.1046/j.1365-2036.16.s4.2.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

1.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  M J Carter; A J Lobo; S P L Travis
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.

Authors:  A N Ananthakrishnan; R Guzman-Perez; V Gainer; T Cai; S Churchill; I Kohane; R M Plenge; S Murphy
Journal:  Aliment Pharmacol Ther       Date:  2012-02-23       Impact factor: 8.171

Review 3.  Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis.

Authors:  M J Rosen; P Minar; A A Vinks
Journal:  Aliment Pharmacol Ther       Date:  2015-03-23       Impact factor: 8.171

Review 4.  History of and current issues affecting surgery for pediatric ulcerative colitis.

Authors:  Keiichi Uchida; Toshimitsu Araki; Masato Kusunoki
Journal:  Surg Today       Date:  2012-12-01       Impact factor: 2.549

5.  Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study.

Authors:  Nienke Z Borren; Hamed Khalili; Jay Luther; Francis P Colizzo; John J Garber; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2019-03-14       Impact factor: 5.325

6.  Uygur medicine Xipayi Kui Jie'an affects gene expression profiles in intestinal tissue lesions in a rat model of ulcerative colitis.

Authors:  Kurexi Yunusi; Jingping Zhang; Li Zhong; Gulinisha Mosha; Ajiguli Nuermaimaiti; Mairipaiti Abudula; Halmurat Upur
Journal:  BMC Complement Altern Med       Date:  2015-05-22       Impact factor: 3.659

7.  Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis.

Authors:  Yunliang Wang; Lijuan Liu; Yi Guo; Tangyou Mao; Rui Shi; Junxiang Li
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

8.  Qingchang Wenzhong Decoction Attenuates DSS-Induced Colitis in Rats by Reducing Inflammation and Improving Intestinal Barrier Function via Upregulating the MSP/RON Signalling Pathway.

Authors:  Tangyou Mao; Junxiang Li; Lijuan Liu; Weihan Zhao; Yuyue Liu; Kangli Gao; Yi Guo; Tianhong Xie; Ningfei Li; Rui Shi
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-12       Impact factor: 2.629

9.  Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report.

Authors:  Ana Lorena Sousa de Vasconcelos Garate; Thiara Barcelos Rocha; Luciana Rocha Almeida; Rodrigo Quera; Jaqueline Ribeiro Barros; Julio Pinheiro Baima; Rogerio Saad-Hossne; Ligia Yukie Sassaki
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337

10.  Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis.

Authors:  Jim O'Connell; Jayne Doherty; Amy Buckley; David Cormican; Cara Dunne; Karen Hartery; John Larkin; Finbar MacCarthy; Paul McCormick; Susan McKiernan; Brian Mehigan; Cian Muldoon; Ciara Ryan; Jacintha O'Sullivan; David Kevans
Journal:  Intest Res       Date:  2022-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.